CYTOKINES AND LOCAL CHRONIC INFLAMMATION IN THE FORMATION OF INFERTILITY IN FERTILE AGE WOMEN
Olga Olegovna OBUKHOVA, Alexandr Nikolaevich TRUNOV, Olga Mikhaylovna GORBENKO, Alya Petrovna SHVAYUK
Research Institute for Experimental and Clinical Medicine of Federal Research Center for Fundamental and Translational Medicine
Keywords: хроническое воспаление, цитокины, иммунное реагирование, бесплодие, фертильный возраст, chronic inflammation, cytokines, immune response, infertility, fertile age
Abstract
The purpose of the study
was to examine the characteristics of the content of cytokines in the
peritoneal fluid in women of reproductive age with infertility against
the background of chronic inflammatory diseases of the pelvic organs in
the stage of clinical remission. Material and methods. A study was
conducted of 50 patients aged 23-36 years with a verified diagnosis of
infertility of tubal peritoneal genesis against a background of chronic
inflammatory diseases of the reproductive sphere in the stage of
clinical remission. As a control group, 15 practically healthy women
aged 25-37 years were examined. Concentration of cytokines TNF-α, IL-4,
IL-6, IL-10, IFN-γ, MCP-1 in the peritoneal fluid was measured by
enzyme-linked immunosorbent assay. Results and discussion. In the main
group of patients with tubal-peritoneal infertility, the activity of
local inflammatory reactions is tested in the period of clinical
remission of a chronic inflammatory process. This is confirmed by a
significantly higher level of TNF-α, IL-4, IL-6, IFN-γ, MCP-1 in the
peritoneal fluid compared to the control group. The studied biologically
active substances play a significant role in the development of the
immune response, as well as fibroplastic processes. The results can be
regarded as the latent development of the immune response in reactions
to constant antigenic stimulation from the focus of chronic
inflammation, which is a significant factor in the development of
adhesions in the formation of infertility, and requires the inclusion of
immunotropic therapy methods in treatment.
|